| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5602430 | Heart, Lung and Circulation | 2017 | 8 Pages |
Abstract
Galectin-3 is a strong, independent prognostic marker in PH, regardless of aetiology. Larger studies should further evaluate the role of galectin-3 as a prognostic biomarker and possible therapeutic target in PH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeremy A. MD, Benjamin D. PhD, MPH, Wajeeha MD, Muhammad R. MD, Ronald MD, PhD,